Metraipolis › archive › dc_a250def205ac

Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L-ALK Positive Lung Squamous Cell Carcinoma With Negative IHC — Europe PMC PMID:42473299

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42473299
DOI
10.1111/1759-7714.70348
License (as archived)
solo-consultazione
Archived
2026-10-18T14:10:49.443Z
SHA-256 of the archived text
0e7f8349dddc92d0de5173bd7edf222d3be32a6e07e12cd5320c5a4553ada16e
Stable URL of this page
https://metraipolis.com/documento/dc_a250def205ac

How to cite

Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L-ALK Positive Lung Squamous Cell Carcinoma With Negative IHC — Europe PMC PMID:42473299 — Europe PMC (en), https://europepmc.org/article/MED/42473299 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a250def205ac (Metraipolis archive dc_a250def205ac, sha256 0e7f8349dddc92d0de5173bd7edf222d3be32a6e07e12cd5320c5a4553ada16e)
BibTeX
@misc{dca250def205ac,
  title = {Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L-ALK Positive Lung Squamous Cell Carcinoma With Negative IHC — Europe PMC PMID:42473299},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42473299},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a250def205ac; sha256 0e7f8349dddc92d0de5173bd7edf222d3be32a6e07e12cd5320c5a4553ada16e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42473299. Agents can read the archived copy with the MCP tool read_document.